Effects of Tryptophan Supplementation and Exercise on the Fate of Kynurenine Metabolites in Mice and Humans.

behavior dietary supplements energy metabolism exercise kynurenine metabolites skeletal muscle tryptophan

Journal

Metabolites
ISSN: 2218-1989
Titre abrégé: Metabolites
Pays: Switzerland
ID NLM: 101578790

Informations de publication

Date de publication:
03 Aug 2021
Historique:
received: 12 07 2021
revised: 29 07 2021
accepted: 30 07 2021
entrez: 26 8 2021
pubmed: 27 8 2021
medline: 27 8 2021
Statut: epublish

Résumé

The kynurenine pathway of tryptophan (TRP) degradation (KP) generates metabolites with effects on metabolism, immunity, and mental health. Endurance exercise training can change KP metabolites by changing the levels of KP enzymes in skeletal muscle. This leads to a metabolite pattern that favors energy expenditure and an anti-inflammatory immune cell profile and reduces neurotoxic metabolites. Here, we aimed to understand if TRP supplementation in untrained vs. trained subjects affects KP metabolite levels and biological effects. Our data show that chronic TRP supplementation in mice increases all KP metabolites in circulation, and that exercise reduces the neurotoxic branch of the pathway. However, in addition to increasing wheel running, we did not observe other effects of TRP supplementation on training adaptations, energy metabolism or behavior in mice. A similar increase in KP metabolites was seen in trained vs. untrained human volunteers that took a TRP drink while performing a bout of aerobic exercise. With this acute TRP administration, TRP and KYN were higher in the trained vs. the untrained group. Considering the many biological effects of the KP, which can lead to beneficial or deleterious effects to health, our data encourage future studies of the crosstalk between TRP supplementation and physical exercise.

Identifiants

pubmed: 34436450
pii: metabo11080508
doi: 10.3390/metabo11080508
pmc: PMC8400416
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Vetenskapsrådet
ID : 2016-00785
Organisme : Novo Nordisk Fonden
ID : NNF19OC0054132
Organisme : National Health and Medical Research Council
Organisme : Macquarie University
Organisme : Svenska Sällskapet för Medicinsk Forskning

Références

Am J Physiol Cell Physiol. 2016 May 15;310(10):C836-40
pubmed: 27030575
Nature. 2011 Oct 05;478(7368):197-203
pubmed: 21976023
Neuroreport. 2001 Mar 26;12(4):871-4
pubmed: 11277599
Br J Sports Med. 2018 Apr;52(7):439-455
pubmed: 29540367
J Biol Chem. 1986 Mar 15;261(8):3648-53
pubmed: 2419335
Sci Rep. 2021 May 27;11(1):11092
pubmed: 34045580
J Exp Biol. 2018 Mar 7;221(Pt Suppl 1):
pubmed: 29514893
Int J Tryptophan Res. 2016 Aug 11;9:51-65
pubmed: 27547037
Science. 2017 Jul 28;357(6349):
pubmed: 28751584
Nat Rev Immunol. 2019 Mar;19(3):184-197
pubmed: 30718831
Neurochem Res. 1990 Nov;15(11):1101-7
pubmed: 2089269
Rapid Commun Mass Spectrom. 2009 May;23(9):1371-9
pubmed: 19337982
J Infect Dis. 2012 Jan 1;205(1):152-61
pubmed: 21990421
Am J Physiol Cell Physiol. 2020 May 1;318(5):C818-C830
pubmed: 32208989
Eur J Pharmacol. 1981 Jul 10;72(4):411-2
pubmed: 6268428
Cell. 2014 Sep 25;159(1):33-45
pubmed: 25259918
Int J Tryptophan Res. 2020 Jul 8;13:1178646920938688
pubmed: 32684749
Neurotoxicol Teratol. 2011 Sep-Oct;33(5):538-47
pubmed: 21763768
Amino Acids. 2001;20(1):25-34
pubmed: 11310928
Cell Metab. 2018 Oct 2;28(4):656-666.e1
pubmed: 30017358
Metabolites. 2020 Dec 23;11(1):
pubmed: 33374836
BMC Bioinformatics. 2006 Mar 09;7:123
pubmed: 16526949
Sports Med. 2020 Jan;50(1):25-53
pubmed: 31531769
Int J Sports Med. 1988 Oct;9(5):301-5
pubmed: 3246461
Eur J Pharmacol. 1988 Sep 1;154(1):85-7
pubmed: 2846328
Cell Metab. 2018 Feb 6;27(2):378-392.e5
pubmed: 29414686
Nat Commun. 2019 Jun 24;10(1):2767
pubmed: 31235694
Neurobiol Aging. 2019 Aug;80:11-20
pubmed: 31055163
Int J Sports Med. 2021 Jan;42(1):33-40
pubmed: 32707579
Int J Tryptophan Res. 2020 Dec 10;13:1178646920978241
pubmed: 33354112
Exerc Immunol Rev. 2020;26:24-42
pubmed: 32139353
Int J Tryptophan Res. 2021 Mar 22;14:11786469211003109
pubmed: 33814916

Auteurs

Paula Valente-Silva (P)

Department of Physiology and Pharmacology, Biomedicum Karolinska Institutet, 171 77 Stockholm, Sweden.

Igor Cervenka (I)

Department of Physiology and Pharmacology, Biomedicum Karolinska Institutet, 171 77 Stockholm, Sweden.

Duarte M S Ferreira (DMS)

Department of Physiology and Pharmacology, Biomedicum Karolinska Institutet, 171 77 Stockholm, Sweden.

Jorge C Correia (JC)

Department of Physiology and Pharmacology, Biomedicum Karolinska Institutet, 171 77 Stockholm, Sweden.

Sebastian Edman (S)

Department of Physiology, Nutrition and Biomechanics, Swedish School of Sport and Health Sciences, 114 33 Stockholm, Sweden.

Oscar Horwath (O)

Department of Physiology, Nutrition and Biomechanics, Swedish School of Sport and Health Sciences, 114 33 Stockholm, Sweden.

Benjamin Heng (B)

Neuroinflammation Group, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sidney, NSW 2109, Australia.

Sharron Chow (S)

Neuroinflammation Group, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sidney, NSW 2109, Australia.

Kelly R Jacobs (KR)

Neuroinflammation Group, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sidney, NSW 2109, Australia.

Gilles J Guillemin (GJ)

Neuroinflammation Group, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sidney, NSW 2109, Australia.

Eva Blomstrand (E)

Department of Physiology, Nutrition and Biomechanics, Swedish School of Sport and Health Sciences, 114 33 Stockholm, Sweden.

Jorge L Ruas (JL)

Department of Physiology and Pharmacology, Biomedicum Karolinska Institutet, 171 77 Stockholm, Sweden.

Classifications MeSH